BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17002060)

  • 1. [Qualitative assessment of metabolic shifts accompanying the acutely progressive course of pulmonary tuberculosis].
    Kaminskaia GO; Abdullaev RIu; Serebrianaia BA
    Probl Tuberk Bolezn Legk; 2006; (8):53-7. PubMed ID: 17002060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the levels of nitric oxide in the mononuclear cells and neutrophils of patients with tuberculosis with varying courses of pulmonary tuberculosis].
    Kaminskaia GO; Abdullaev RIu
    Probl Tuberk Bolezn Legk; 2004; (8):41-5. PubMed ID: 15478558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The specific features of a pathogen in acutely progressive pulmonary tuberculosis].
    Balasaniants GS; Greĭmer MS
    Probl Tuberk Bolezn Legk; 2003; (9):29-31. PubMed ID: 14598524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iron metabolism in patients with different variants of pulmonary tuberculosis].
    Kaminskaia GO; Abdullaev RIu
    Probl Tuberk; 2002; (12):49-51. PubMed ID: 12611338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum nitric oxide level in the assessment of systemic inflammation in patients with drug-resistant pulmonary tuberculosis].
    Abdullaev RIu; Kaminskaia GO; Komissarova OG; Glotova EV
    Probl Tuberk Bolezn Legk; 2009; (5):40-3. PubMed ID: 19565813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Red blood cell metabolic changes in patients with acutely progressive pulmonary tuberculosis].
    Kaminskaia GO; Abdullaev RIu
    Probl Tuberk; 2002; (2):33-6. PubMed ID: 11899803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood anticoagulation system in the hypercoagulation syndrome in patients with pulmonary tuberculosis].
    Kaminskaia GO; Martynova EV; Serebrianaia BA; Komissarova OG
    Probl Tuberk Bolezn Legk; 2008; (11):35-9. PubMed ID: 19140378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic and prognostic significance of adenosine deaminase in acutely progressive pulmonary tuberculosis].
    Balasaniants GS; Titarenko OT; D'iakova MN
    Probl Tuberk; 2001; (8):46-9. PubMed ID: 11767393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of nitric oxide profile in new cases of focal infiltrative pulmonary tuberculosis].
    Ratnikov VI; Bubochkin BP; Potapov IV
    Probl Tuberk Bolezn Legk; 2003; (12):26-8. PubMed ID: 15004968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The level of lipid peroxidation products and the parameters of antioxidative defense in the expired air condensate in patients with respiratory tuberculosis].
    Khyshiktuev BS; Baĭke EE
    Probl Tuberk Bolezn Legk; 2004; (9):39-41. PubMed ID: 15532467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of endotoxicosis in pulmonary tuberculosis].
    Duntau AP; Efremov AV; Bakaev VV
    Probl Tuberk; 2000; (1):37-9. PubMed ID: 10750429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the morphological diagnosis of drug-resistant pulmonary tuberculosis].
    Ziuzia IuR; Lepekha LN; Gedymin LE; Burtseva SA; Erokhin VV
    Probl Tuberk Bolezn Legk; 2006; (10):56-60. PubMed ID: 17139834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa; Zhangireev AA; Sidorenko OA
    Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infiltrative pulmonary tuberculosis: course and efficiency of treatment].
    Mishin VIu; Nazarova NV; Kononen AS; Miakishev TV; Sadovski AI
    Probl Tuberk Bolezn Legk; 2006; (10):7-12. PubMed ID: 17139824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary drug resistance in Mycobacterium tuberculosis among patients with pulmonary tuberculosis and its impact on permanent disability in the Volgograd region].
    Borzenko AS; gagarina SG; Samoĭlova IV; Kalushenina AA
    Probl Tuberk Bolezn Legk; 2007; (12):28-30. PubMed ID: 18326212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute toxic encephalopathy in patients with tuberculosis].
    Korniliva ZKh; Khokhlov IuK; Savin AA; Batyrov FA
    Probl Tuberk; 2002; (12):42-6. PubMed ID: 12611336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrosternal lymphotropic chemotherapy and pneumoperitoneum in the treatment of drug-resistant destructive pulmonary tuberculosis].
    Kibrik BS; Zakharov AV; Lobanovskiĭ VM
    Probl Tuberk Bolezn Legk; 2009; (5):21-6. PubMed ID: 19565808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1-acid glycoprotein, its local production and immunopathological participation in experimental pulmonary tuberculosis.
    Martìnez Cordero E; Gonzàlez MM; Aguilar LD; Orozco EH; Hernàndez Pando R
    Tuberculosis (Edinb); 2008 May; 88(3):203-11. PubMed ID: 18055265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with small-volume plasmapheresis used in the correction of hemostatic disorders in patients with progressive destructive pulmonary tuberculosis].
    Karpina NL; Kaminskaia GO; Serebrianaia BA; Erokhin VV
    Probl Tuberk Bolezn Legk; 2007; (11):33-7. PubMed ID: 18080532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.